滔搏(06110.HK):第一財季零售及批發業務的總銷售金額同比錄得中單位數下跌
格隆匯6月27日丨滔搏(06110.HK)公佈,於2024/25財政年度第一季度((由2024年3月1日至2024年5月31日的三個月)),集團零售及批發業務的總銷售金額按年同比錄得中單位數下跌。
截至2024年5月31日,直營門店毛銷售面積較上一季末減少1.4%,較去年同期減少0.5%。
零售業務的銷售金額為零售門店(線下渠道)及電子商務平台(線上渠道)與消費者進行銷售業務的收益(包含但不限於增值税);批發業務的銷售金額為集團與下游零售商進行銷售業務的收益(包含但不限於增值税)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.